Value Based Care Landscape- A Private Equity Perspective

Value-Based Care Market—Growth & Opportunity

Market Size & Growth:

US value-based healthcare services market is projected to grow from $3.6B in 2024 to $8.1B by 2034 at an 8.6% CAGR.
Broader US VBC service market expected to reach $6.16T by 2030, growing at 7.4% CAGR.

Global Perspective:

Global VBC market to reach $37.57B by 2032 at a 17.4% CAGR.

Investor Takeaway:

The sector is experiencing robust, sustained growth driven by payer, provider, and regulatory shifts.

Source: etkho

Key Drivers Accelerating Value-Based Care Adoption

Cost & Outcomes Pressure: Rising healthcare costs and chronic disease prevalence are pushing payers and providers toward VBC models.

Policy & Regulation: CMS aims for all Medicare providers to enter two-sided risk arrangements and half of commercial/Medicaid contracts to be value-based by 2025.

Technology & Digital Health: AI, big data analytics, and digital health platforms are enabling scalable VBC solutions and improved care coordination.

Patient-Centered Care: Focus on patient outcomes, satisfaction, and preventive care is central to VBC’s rapid adoption.

Competitive Landscape & Investment Hotspots

Major Players:

MVP Health Care
Humana
Blue Cross and Blue Shield of North Carolina
UnitedHealth Group
Cigna Healthcare

Emerging Opportunities:

Growth in home-based, virtual care, and population health management.
Expansion beyond primary care into specialties like oncology, orthopedics, and chronic disease management.

Investor Strategy: Target scalable platforms, tech-enabled providers, and companies with strong payer partnerships.

Challenges and Risk Factors for Investors

Transition Complexity: Providers face operational and financial risk in shifting from fee-for-service to VBC, requiring investment in analytics and care coordination.

Data & Infrastructure: Success in VBC depends on robust data collection, privacy compliance, and advanced IT infrastructure.

Market Fragmentation: Balancing legacy payment models with VBC arrangements can limit growth in some regions.

Regulatory Uncertainty: Ongoing policy changes and regional disparities require careful due diligence and flexible investment approaches.

Strategic Recommendations for PE Investors

Prioritize Tech-Enabled Assets:

Invest in companies leveraging AI, analytics, and digital health to drive outcomes and efficiency.

Focus on Scalable, Patient-Centric Models:

Favor platforms that can expand across geographies and specialties, with proven patient engagement and satisfaction.

Partnerships & Integration:

Seek opportunities with strong payer-provider collaboration and integrated care delivery.

Monitor Regulatory Trends:

Stay agile to adapt to evolving CMS and state-level VBC mandates.

Prepare for Long-Term Value Creation:

VBC investments may require longer time horizons but offer significant returns as the market matures and consolidates.

PE’s Billion-Dollar Bet on Population Health Analytics

What technological innovations are PE-backed practices adopting to improve VBC outcomes?

Health IT Investments: PE firms are investing in revenue cycle management, digital front doors (e.g., online scheduling, telehealth), and advanced EHR systems to streamline operations and improve patient engagement.

Data Analytics: Practices are adopting population health analytics and predictive modeling to identify at-risk patients and tailor interventions, supporting VBC goals.

Care Coordination Tools: Enhanced care management platforms and integrated communication systems are being deployed to improve chronic disease management and care transitions.

Specialty-Specific Tech: In specialties like anesthesiology and gastroenterology, PE-backed groups are implementing scalable clinical workflow solutions and telemedicine to increase efficiency and reach.

Outcome Tracking: These innovations enable better measurement of quality metrics, cost savings, and patient outcomes, aligning with value-based care incentives.

How might increased consolidation driven by PE affect healthcare competition locally?

Market Concentration: PE acquisitions are consolidating fragmented markets, particularly in outpatient and specialty care, leading to fewer, larger provider groups.

Pricing Power: Studies show PE-acquired practices often negotiate higher prices with payers, resulting in increased costs per claim and higher allowed amounts for services.

Utilization Increases: After acquisition, PE-backed practices see more unique patients and higher encounter volumes, partly due to expanded marketing and operational scale.

Potential Downsides: Reduced competition may limit patient choice, increase healthcare spending, and make it harder for independent practices to survive.

Regulatory Attention: These trends have prompted scrutiny from policymakers and antitrust authorities concerned about market power and its effects on cost and access.

PE Investments in Health Care in the US, 2005–2023

Source:chcf.org

PE Acquisitions of Health Care Service Providers in the US, 2005–2023

Source:chcf.org

PE Investment in Health Care in California, 2005–2023

Source:chcf.org

What HCIT innovations are PE-backed practices implementing to enhance value-based care outcomes?

PE-backed practices are investing in advanced EHRs, telehealth, and digital scheduling to improve patient engagement and care coordination.
Population health analytics and predictive modeling are used to identify at-risk patients and tailor interventions, supporting value-based care (VBC) contracts.
Enhanced revenue cycle management and automated billing systems improve financial performance and compliance.
Specialty practices are adopting workflow automation and remote monitoring to increase efficiency and quality.

Total valuations of value-based care assets could reach $1 trillion

Distribution of projected healthcare EBITDA across healthcare segments, 2028, $ billion

Key US Healthcare Investment Trends to Identify High-Growth Opportunities in 2026

Outpatient and Ambulatory Care: Continued fragmentation in outpatient surgery centers, urgent care, and specialty clinics (e.g., dermatology, orthopedics) creates roll-up and platform-building opportunities.

Behavioral Health & Home-Based Care: Demand for mental health, substance use treatment, and home health services is surging, driven by payer incentives and consumer demand.

Healthcare IT & Value-Based Care Enablers: PE is targeting digital health, population health analytics, and care coordination platforms that support value-based care (VBC) contracts.

Specialty Physician Groups: Cardiology, gastroenterology, and women’s health practices are attracting PE due to reimbursement stability and consolidation potential.

How Consolidation in Diagnostics & Medical Devices Shapes US PE Exit Strategies?

Strategic Acquisitions: Consolidation in diagnostics (e.g., lab services, imaging centers) and medtech enables PE to build scale and operational efficiency, making assets attractive to large strategics and public markets.

Exit Pathways: Most lucrative exits are via strategic sales to national health systems, lab networks, or device manufacturers; IPOs are also viable for scaled, tech-enabled platforms.

Regulatory Environment: Increased FTC/DOJ scrutiny of healthcare consolidation requires careful deal structuring and proactive compliance.

Value Drivers: Integrated platforms with strong payer relationships, tech-enabled workflow, and geographic reach command premium valuations.

How AI Advancements Can Improve the Value of US Healthcare Portfolio Investments?

Revenue Cycle & Operations: AI-driven automation in billing, coding, and scheduling increases efficiency and reduces administrative costs in provider groups and outpatient centers.

Clinical Decision Support: AI is being deployed for imaging analysis, risk stratification, and remote patient monitoring—improving outcomes and enabling new service lines.

Patient Engagement: AI-powered chatbots, appointment reminders, and personalized care plans are boosting retention and satisfaction, key for VBC models.

Portfolio Differentiation: Early adoption of AI solutions can make portfolio companies more attractive for strategic buyers and public markets, supporting higher exit multiples.

Major Players in Population Health Analytics

Arcadia

Arcadia is a leading US-based healthcare data analytics platform specializing in integrating and harmonizing data from EHRs, claims, SDoH, and remote monitoring. Their platform delivers actionable insights for population health management, value-based care optimization, risk adjustment, and care gap closure. Arcadia is recognized for its AI-powered analytics and data governance capabilities.

Funding: $125 million from Vista Credit Partners in April 2023.